IBDEI0H8 ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,7759,1,4,0)
;;=4^I25.708
;;^UTILITY(U,$J,358.3,7759,2)
;;=^5007119
;;^UTILITY(U,$J,358.3,7760,0)
;;=I25.709^^39^389^20
;;^UTILITY(U,$J,358.3,7760,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7760,1,3,0)
;;=3^Athscl of CABG,Unspec w/ Unspec Angina Pectoris
;;^UTILITY(U,$J,358.3,7760,1,4,0)
;;=4^I25.709
;;^UTILITY(U,$J,358.3,7760,2)
;;=^5007120
;;^UTILITY(U,$J,358.3,7761,0)
;;=I25.700^^39^389^21
;;^UTILITY(U,$J,358.3,7761,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7761,1,3,0)
;;=3^Athscl of CABG,Unspec w/ Unstable Angina Pectoris
;;^UTILITY(U,$J,358.3,7761,1,4,0)
;;=4^I25.700
;;^UTILITY(U,$J,358.3,7761,2)
;;=^5007117
;;^UTILITY(U,$J,358.3,7762,0)
;;=I82.469^^39^389^24
;;^UTILITY(U,$J,358.3,7762,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7762,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Acute
;;^UTILITY(U,$J,358.3,7762,1,4,0)
;;=4^I82.469
;;^UTILITY(U,$J,358.3,7762,2)
;;=^5158066
;;^UTILITY(U,$J,358.3,7763,0)
;;=I82.569^^39^389^25
;;^UTILITY(U,$J,358.3,7763,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7763,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Chronic
;;^UTILITY(U,$J,358.3,7763,1,4,0)
;;=4^I82.569
;;^UTILITY(U,$J,358.3,7763,2)
;;=^5158074
;;^UTILITY(U,$J,358.3,7764,0)
;;=I80.259^^39^389^33
;;^UTILITY(U,$J,358.3,7764,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7764,1,3,0)
;;=3^Phlebitis & Thrombophlebitis,Unspec Calf Muscle Vein
;;^UTILITY(U,$J,358.3,7764,1,4,0)
;;=4^I80.259
;;^UTILITY(U,$J,358.3,7764,2)
;;=^5158058
;;^UTILITY(U,$J,358.3,7765,0)
;;=I82.409^^39^389^26
;;^UTILITY(U,$J,358.3,7765,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7765,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
;;^UTILITY(U,$J,358.3,7765,1,4,0)
;;=4^I82.409
;;^UTILITY(U,$J,358.3,7765,2)
;;=^5133625
;;^UTILITY(U,$J,358.3,7766,0)
;;=I82.509^^39^389^27
;;^UTILITY(U,$J,358.3,7766,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7766,1,3,0)
;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
;;^UTILITY(U,$J,358.3,7766,1,4,0)
;;=4^I82.509
;;^UTILITY(U,$J,358.3,7766,2)
;;=^5133628
;;^UTILITY(U,$J,358.3,7767,0)
;;=E78.1^^39^390^23
;;^UTILITY(U,$J,358.3,7767,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7767,1,3,0)
;;=3^Pure Hyperglyceridemia
;;^UTILITY(U,$J,358.3,7767,1,4,0)
;;=4^E78.1
;;^UTILITY(U,$J,358.3,7767,2)
;;=^101303
;;^UTILITY(U,$J,358.3,7768,0)
;;=E78.2^^39^390^21
;;^UTILITY(U,$J,358.3,7768,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7768,1,3,0)
;;=3^Mixed Hyperlipidemia
;;^UTILITY(U,$J,358.3,7768,1,4,0)
;;=4^E78.2
;;^UTILITY(U,$J,358.3,7768,2)
;;=^78424
;;^UTILITY(U,$J,358.3,7769,0)
;;=I10.^^39^390^9
;;^UTILITY(U,$J,358.3,7769,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7769,1,3,0)
;;=3^Essential Primary Hypertension
;;^UTILITY(U,$J,358.3,7769,1,4,0)
;;=4^I10.
;;^UTILITY(U,$J,358.3,7769,2)
;;=^5007062
;;^UTILITY(U,$J,358.3,7770,0)
;;=I11.9^^39^390^19
;;^UTILITY(U,$J,358.3,7770,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7770,1,3,0)
;;=3^Hypertensive Heart Disease w/o Heart Failure
;;^UTILITY(U,$J,358.3,7770,1,4,0)
;;=4^I11.9
;;^UTILITY(U,$J,358.3,7770,2)
;;=^5007064
;;^UTILITY(U,$J,358.3,7771,0)
;;=I11.0^^39^390^18
;;^UTILITY(U,$J,358.3,7771,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,7771,1,3,0)
;;=3^Hypertensive Heart Disease w/ Heart Failure
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0H8 3745 printed Apr 09, 2024@21:47:24 Page 2
IBDEI0H8 ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,7759,1,4,0)
+2 ;;=4^I25.708
+3 ;;^UTILITY(U,$J,358.3,7759,2)
+4 ;;=^5007119
+5 ;;^UTILITY(U,$J,358.3,7760,0)
+6 ;;=I25.709^^39^389^20
+7 ;;^UTILITY(U,$J,358.3,7760,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,7760,1,3,0)
+10 ;;=3^Athscl of CABG,Unspec w/ Unspec Angina Pectoris
+11 ;;^UTILITY(U,$J,358.3,7760,1,4,0)
+12 ;;=4^I25.709
+13 ;;^UTILITY(U,$J,358.3,7760,2)
+14 ;;=^5007120
+15 ;;^UTILITY(U,$J,358.3,7761,0)
+16 ;;=I25.700^^39^389^21
+17 ;;^UTILITY(U,$J,358.3,7761,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,7761,1,3,0)
+20 ;;=3^Athscl of CABG,Unspec w/ Unstable Angina Pectoris
+21 ;;^UTILITY(U,$J,358.3,7761,1,4,0)
+22 ;;=4^I25.700
+23 ;;^UTILITY(U,$J,358.3,7761,2)
+24 ;;=^5007117
+25 ;;^UTILITY(U,$J,358.3,7762,0)
+26 ;;=I82.469^^39^389^24
+27 ;;^UTILITY(U,$J,358.3,7762,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,7762,1,3,0)
+30 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Acute
+31 ;;^UTILITY(U,$J,358.3,7762,1,4,0)
+32 ;;=4^I82.469
+33 ;;^UTILITY(U,$J,358.3,7762,2)
+34 ;;=^5158066
+35 ;;^UTILITY(U,$J,358.3,7763,0)
+36 ;;=I82.569^^39^389^25
+37 ;;^UTILITY(U,$J,358.3,7763,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,7763,1,3,0)
+40 ;;=3^Embolism/Thrombosis,Unspec Calf Muscle Vein,Chronic
+41 ;;^UTILITY(U,$J,358.3,7763,1,4,0)
+42 ;;=4^I82.569
+43 ;;^UTILITY(U,$J,358.3,7763,2)
+44 ;;=^5158074
+45 ;;^UTILITY(U,$J,358.3,7764,0)
+46 ;;=I80.259^^39^389^33
+47 ;;^UTILITY(U,$J,358.3,7764,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,7764,1,3,0)
+50 ;;=3^Phlebitis & Thrombophlebitis,Unspec Calf Muscle Vein
+51 ;;^UTILITY(U,$J,358.3,7764,1,4,0)
+52 ;;=4^I80.259
+53 ;;^UTILITY(U,$J,358.3,7764,2)
+54 ;;=^5158058
+55 ;;^UTILITY(U,$J,358.3,7765,0)
+56 ;;=I82.409^^39^389^26
+57 ;;^UTILITY(U,$J,358.3,7765,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,7765,1,3,0)
+60 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Acute
+61 ;;^UTILITY(U,$J,358.3,7765,1,4,0)
+62 ;;=4^I82.409
+63 ;;^UTILITY(U,$J,358.3,7765,2)
+64 ;;=^5133625
+65 ;;^UTILITY(U,$J,358.3,7766,0)
+66 ;;=I82.509^^39^389^27
+67 ;;^UTILITY(U,$J,358.3,7766,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,7766,1,3,0)
+70 ;;=3^Embolism/Thrombosis,Unspec Deep Vein,LE Unspec Chronic
+71 ;;^UTILITY(U,$J,358.3,7766,1,4,0)
+72 ;;=4^I82.509
+73 ;;^UTILITY(U,$J,358.3,7766,2)
+74 ;;=^5133628
+75 ;;^UTILITY(U,$J,358.3,7767,0)
+76 ;;=E78.1^^39^390^23
+77 ;;^UTILITY(U,$J,358.3,7767,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,7767,1,3,0)
+80 ;;=3^Pure Hyperglyceridemia
+81 ;;^UTILITY(U,$J,358.3,7767,1,4,0)
+82 ;;=4^E78.1
+83 ;;^UTILITY(U,$J,358.3,7767,2)
+84 ;;=^101303
+85 ;;^UTILITY(U,$J,358.3,7768,0)
+86 ;;=E78.2^^39^390^21
+87 ;;^UTILITY(U,$J,358.3,7768,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,7768,1,3,0)
+90 ;;=3^Mixed Hyperlipidemia
+91 ;;^UTILITY(U,$J,358.3,7768,1,4,0)
+92 ;;=4^E78.2
+93 ;;^UTILITY(U,$J,358.3,7768,2)
+94 ;;=^78424
+95 ;;^UTILITY(U,$J,358.3,7769,0)
+96 ;;=I10.^^39^390^9
+97 ;;^UTILITY(U,$J,358.3,7769,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,7769,1,3,0)
+100 ;;=3^Essential Primary Hypertension
+101 ;;^UTILITY(U,$J,358.3,7769,1,4,0)
+102 ;;=4^I10.
+103 ;;^UTILITY(U,$J,358.3,7769,2)
+104 ;;=^5007062
+105 ;;^UTILITY(U,$J,358.3,7770,0)
+106 ;;=I11.9^^39^390^19
+107 ;;^UTILITY(U,$J,358.3,7770,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,7770,1,3,0)
+110 ;;=3^Hypertensive Heart Disease w/o Heart Failure
+111 ;;^UTILITY(U,$J,358.3,7770,1,4,0)
+112 ;;=4^I11.9
+113 ;;^UTILITY(U,$J,358.3,7770,2)
+114 ;;=^5007064
+115 ;;^UTILITY(U,$J,358.3,7771,0)
+116 ;;=I11.0^^39^390^18
+117 ;;^UTILITY(U,$J,358.3,7771,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,7771,1,3,0)
+120 ;;=3^Hypertensive Heart Disease w/ Heart Failure
